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ABSTRACT 
Introduction: The aim of the study was to evaluate quality of life (QoL) in patients with colorectal cancer 
during complex treatment using the EORTC QLQ-C30 and QLQ-CR29 questionnaires and to implement 
routine QoL assessment into our practice. 
Methods: Thirty patients diagnosed with colorectal cancer at the Department of Surgery, Faculty Hospital 
Trnava, Slovakia were included in the study between May 2014 and April 2015. QoL was assessed using 
EORTC QLQ-C30 and QLQ-CR29 questionnaires before surgery and 1 month after surgery. Data are 
presented as means, and a paired t-test and independent t-test were used for statistical analysis. 
Results: A significant correlation between the type of treatment and QoL was identified in the cohort. A 
trend to lower QoL was observed in patients with completed neoadjuvant chemoradiotherapy and after 
surgery with stoma formation. The QoL was also affected by the age and gender of the patients. 
Conclusion: QoL assessment provides important outcomes reflecting the consequences of particular 
therapeutic modality in patients with colorectal cancer. The worse effect of neoadjuvant 
chemoradiotherapy and stoma formation was shown in our study in comparison to radical resection with 
adjuvant chemotherapy. 
Keywords: quality of life, questionnaire, EORTC, QLQ-C30, QLQ-CR29, colorectal cancer 
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INTRODUCTION 
The growing incidence of colorectal cancer (CRC) is alarming. There are 940 000 new cases 
diagnosed and a mortality of approximately 500 000 patients annually worldwide [1]. Slovakia 
remains in the top five countries with the highest incidence and mortality, with 3000 new cases of 
CRC annually. 
CRC is the most frequent malignancy of the gastrointestinal tract. Management of patients with 
CRC usually combines a multimodal causal treatment with symptomatic therapy and management 
of side effects [2]. Surgery remains the first treatment option, commonly in combination with 
neoadjuvant or adjuvant therapy with regards to disease staging and location.  
The diagnosis of CRC and the following treatment lead to complex psychomotor, functional, and 
social impairment, which all affect quality of life (QoL) [3]. Recently, QoL has been considered 
to be an important component of treatment outcomes. Therefore, research became more focused 
on psychosomatic and physical well-being [4]. 
The QLQ-CR29 questionaire was developed by the EORTC (European Organization for Research 
and Treatment of Cancer) and is widely used in CRC patients within Europe. 
Slovak validation of QLQ-CR29 was completed at the Department of Surgery, Faculty Hospital 
Trnava in collaboration with EORTC. 
The aim of the study was to evaluate QoL in patients with CRC during complex treatment using 
EORTC QLQ-C30 and QLQ-CR29 questionnaires and to implement routine QoL assessment into 
practice. 
 
METHODS 
 
The observational study was performed and data are presented using descriptive statistics.  
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Forty-six patients with CRC were considered eligible for the study. The participation in the trial 
was voluntary. From a total of 46 patients, 30 (65.2%) patients were included: 20 (67%) men and 
10 (33%) women. The average age was 63.7 years with a range of 42 – 81 years. In total, 12 (40%) 
patients were <65 and 18 (60%) were ≥65 years of age. With respect to tumour location, 19 (63%) 
patients were diagnosed with colon cancer and 11 patients (37%) were diagnosed with rectal 
cancer. Resection with and without primary stoma formation was performed in 14 (46%) and 5 
(17%) patients with colon cancer and in 6 (20%) and 5 (17%) with rectal cancer, respectively 
(Table 1). Of 11 (100%) patients with rectal cancer, 9 patients (82%) underwent neoadjuvant 
chemoradiotherapy (CRT). 
 
QoL questionnaire 
Data collection was performed using the EORTC QoL Questionnaire C30 (EORTC QLQ-C30) 
and the EORTC QLQ-CR29 module at the Department of Surgery, Faculty Hospital Trnava, 
Slovakia, from May 2014 until April 2015. 
All patients with CRC included in the study completed a validated questionnaire in the Slovak 
language before the initiation of treatment and 1 month after surgery.  
Each patient was informed by a clinician about the diagnosis before the first assessment. The 
patients completed the questionnaire independently with adequate time provided. 
The cohort of 46 patients was divided into two groups depending on the tumour location: group 1 
included patients with colon cancer and group 2 included patients with rectal cancer (tumour 
located within 15 cm from linea dentata). Data from the questionnaires were processed using the 
original software provided by the EORTC.  
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Statistical analysis 
Data were analysed with Statistical software SPSS 22.0.01 using means with standard deviations, 
a paired t-test and independent t-test. Both groups were compared using an independent t-test. The 
difference between pre and postoperative QoL outcomes was assessed with a paired t-test. P value 
≤ 0.05 was statistically significant. 
 
RESULTS 
The comparison of QoL in patients with colon cancer (group 1) and rectal cancer (group 2) is 
presented in Table 2 (table 2). 
The mean global health status of the cohort was 42.4–43.4 preoperatively and these values 
increased to 47.7–52.6 one month after the procedure. The patients with colon and rectal cancer 
differed significantly in the score of buttock pain 1 month after surgery (p=0.001).  
A significant difference was also observed between these two groups in mouth dryness (p=0.042), 
impotence (p=0.035) and sore skin around the anus in patients without stoma (p=0.039).  
The outcomes of QoL assessment in patients with CRC stratified by age are presented in Table 3 
(table 3). 
The mean global health status was 30.6–52.8 within the whole cohort. A significant difference 
between the two age groups was found before the surgery (p=0,007). The score of sexual interest 
in the group of men differed significantly between these groups before (p=0.020) and after surgery 
(p=0.007). The fatigue score and the constipation score showed significant differences (p=0.019 
and p=0.028, respectively) before the operation. One month after surgery a statistically significant 
difference was observed in financial difficulties (p=0.020).   
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The outcomes of QoL evaluation in patients with CRC stratified by gender is shown in Table 4 
(table 4). 
The mean global health status was preoperatively less than 50.0 in both genders. In the second 
assessment, 1 month after surgery, the scores for men and women were 47.1 and 58.3, respectively. 
A significant difference was found between men and women for body image (p=0.031) and 
constipation scores (p=0.007) one month after surgery. There was also a significant difference 
identified for anxiety before surgery (p=0.023).  
The evaluation of QoL in patients with and without stoma is presented in Table 5. 
The mean global health status of the studied sample was 36.7–51.7. A significant difference was 
identified in the physical functioning domain between patients with and without stoma 1 month 
after surgery (48.0 versus 70.7; p=0.024). A statistically significant difference was found in the 
fatigue score preoperatively (p=0.045) and 1 month after surgery (p=0.047).  
 
The evaluation of QoL in patients with rectal cancer with and without neoadjuvant CRT is 
presented in Table 6. 
The mean global health status of patients in the studied cohort was 41.7–50.0. A significant 
difference between patients who were not treated with neoadjuvant CRT and who completed 
neoadjuvant treatment was observed in the cognitive functioning domain in the time before surgery 
(p=0.010). The presence of blood and mucus in stool was more frequent in the group with 
completed neoadjuvant CRT one month after surgery (p=0.023).  
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DISCUSSION 
CRC represents the most common malignant tumour of the gastrointestinal tract and the second 
most frequent malignancy after lung cancer in men and breast and ovarian cancer in women [5]. 
Loss of health integrity due to presence of CRC or the consequences of its treatment can lead to 
psychomotor, functional and social disability, which all affect QoL [3]. QoL is an important 
treatment outcome for overall survival in each individual patient and the concept of QoL gained a 
specific place in nursing. This is closely related to human needs, health, self-sufficiency, well-
being, and daily activities [6]. The QoL is influenced by various spheres of life, individual 
expectations and perception of needs. The importance of particular dimensions can vary during 
the disease and during life itself [3]. 
The variability of symptoms, which depend on tumour localization, the strategy of neoadjuvant 
treatment, the extent of surgery, and adjuvant therapy can lead to different and individual QoL 
outcomes in patients with CRC. 
The mean global health status score varied in our sample between 42.4–52.6. Statistically 
significant differences between patients with colon and rectal cancer was found 1 month after 
surgery for ratings of buttock pain (p=0.001), mouth dryness (p=0.042), impotence (p=0.035) and 
sore skin around the anus in patients without stoma (p=0.039).  
The outcomes from our research differ from Ramsey et al. [7], who studied 227 patients with CRC 
and observed high scores of QoL, regardless of tumour localization, staging, and disease duration. 
Comorbidities and financial problems were of significantly higher negative impact.  
Our findings are, on the other hand, supported by Bernadic and Pechan [8] who reported 
postoperative QoL correlating with the site of surgery and its complexity. The technique of radical 
colon cancer resection is less demanding than rectal surgery for multiple reasons such as different 
mesentery, easier manipulation with the colon and better visualization of constructed anastomosis. 
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The incidence of CRC increases with age. For example, in the U.S.A., the incidence in 45, 55, 65, 
and 75 years old patients is 10, 30, 90, and 200/100 000 respectively.  The peak of CRC incidence 
is at 65–70 years of age. However, a patient’s higher age is not a contraindication for therapeutic 
interventions including biological treatment. In older patients, the indication is modified by lower 
levels of fitness, comorbidities, and poor social background [9, 10].  
Marventano states the outcomes of QoL assessment in patients with CRC are controversial 
regarding age. Some studies showed that QoL improves with age, while the others report a lower 
QoL in older patients [11]. 
In our cohort of CRC patients with ≥65 and <65 years of age, the mean global health score varied 
between 30.6–52.8 and a statistically significant difference was observed between these groups 
preoperatively (p=0.007). A significant difference between these groups was also found for sexual 
interest in subgroups of men preoperatively (p=0.020) and 1 month postoperatively (p=0.007). 
Preoperatively, these two groups of ≥65 and <65 years old showed a significant difference in the 
fatigue score (p=0.019) and constipation score (p=0.028). One month after surgery, there was a 
statistically significant difference in financial problems (p=0.020). 
Similar outcomes were published by Arndt et al., who found a difference between two age groups 
(≥60 and <60 years old). They found that the group below 60 had more financial problems. A 
lower score in the physical functioning domain was observed in patients who returned to work 
after completing treatment [12]. On the other hand, Forsberg et. al. (1996) did not confirm age as 
an indicator of QoL in patients with CRC [13]. 
Gender affects the incidence of CRC. Men have significantly higher incidence of CRC especially 
in rectal cancer. The ratio between colon and rectal cancer varies in different countries [9]. Natrah 
et al. performed a study in 2011 on a group of 100 patients in Malaysia. The authors reported 
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a statistically significant difference in cognitive functions between male and female patients. Men 
showed better cognitive functions in comparison with women. Mean scores of symptoms (fatigue, 
pain, nausea and vomiting, constipation, diarrhoea, insomnia, shortness of breath, loss of appetite) 
varied between 4.00 and 20.7. Women showed worse symptoms for pain, fatigue and shortness of 
breath [14]. 
In our research, the gender adjusted mean global health status score varied between 40.8 and 58.3. 
A statistically significant difference between men and women was observed one month after the 
surgical procedure for body image (p=0.031) and constipation (p=0.007). Preoperatively, a 
significant difference was found for anxiety (p=0.023).  
Similar results were published in a German study by Arndt et al. who assessed 439 patients with 
CRC one year from diagnosis using QLQ-C30 questionnaire. The most significant differences 
were gender related. Men reported better outcomes in emotional and cognitive components of QoL 
than women. On the other hand, the female patient achieved the worst results for pain, insomnia, 
tiredness, constipation and loss of appetite [4].  
Hendren et al. performed a trial on sexual dysfunction in male and female patients after rectal 
cancer surgery. In total, 81 women and 99 men were included. Of the sexual problems evaluated 
by the EORTC questionnaire, women reported changes in libido, and pain and discomfort during 
intercourse. Male patients reported changes in libido, impotence, and partial impotence. Both 
genders perceived their body image negatively. The authors suggested that the risk of sexual 
dysfunction is rarely discussed prior to rectal cancer surgery and little attention is payed to the 
treatment of these complications [15]. 
Patients with stoma experience a number of losses, such as the loss of ability to control defecation 
and passage of gas, which can affect normal social life and lead to negative feelings and social and 
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psychological isolation. Patients lose dignity, have feelings of inferiority, and their body image 
and self-esteem suffer. Many times they are not able to face these situations and are self-disgusted 
[16]. 
In our study, the stoma adjusted mean global health status was 36.7–51.7. In physical functioning, 
a significant difference was observed 1 month after surgery between patients with and without 
stoma (p=0.024). Moreover, a statistical difference was found before (p=0.045) and one month 
after surgery (p=0.047) for the fatigue score. 
Bossema et al. studied rectal cancer patients with and without stoma with regards to global health 
status, and emotional and cognitive functioning. The EORTC-C30 questionnaire was completed 
by a total of 122 patients. Of these, 62 had abdominoperineal resection with permanent stoma and 
60 had low anterior resection without stoma. No significant differences were found between 
patients with and without stoma for any of the parameters. A stronger correlation between disease 
acceptance and QoL in relation to health was observed in non-stoma patients [17]. 
Sprangers et al. published a meta-analysis focused on QoL in CRC patients with and without 
stoma. Of all searched papers published between 1969 and 1992, 17 studies were identified, which 
evaluated at least one of four aspects of patient functioning (physical, psychical, social, and sexual) 
and compared the groups with and without stoma. The study concluded that both groups of patients 
suffer from frequent irregular bowel motions and diarrhoea. However, patients with stoma reported 
higher psychical distress. Both groups reported deterioration in social functioning. However, these 
problems are more common in patients with colostomy [18].  
Radiotherapy remains a part of a multimodal approach and is currently applied either as a 
neoadjuvant or adjuvant treatment [19]. According to Büchler, radiotherapy plays an important 
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role in reduction of local recurrence and palliative therapy of both symptomatic and high risk 
metastatic lesions [10]. 
In our research, the rectal cancer patients with and without complete CRT were compared. The 
mean global health status of these patients was 41.7–50.0. A significant difference between the 
above mentioned groups was found in cognitive functioning (p=0.010) and in blood and mucus in 
stool 1 month after surgery (p=0.023).  
Arndt et al. presented QoL outcomes one year after diagnosis and after treatment (surgery, 
chemotherapy, and/or radiotherapy). Higher scores for physical and cognitive functioning, but 
lower scores for emotional functioning were observed while 80% of patients felt depressed, 
irritated, nervous and fearful [12].  
A Norwegian prospective study including 42 patients with rectal cancer was published by Guren 
et al. in 2003 that evaluated symptoms and QoL during neoadjuvant radiotherapy. QLQ-CR38 was 
completed at the beginning, at the end of radiotherapy and 4–6 weeks afterwards. The scores for 
diarrhoea, fatigue, and loss of appetite were higher after radiation compared to initial values. The 
authors found 64% of patients felt fatigue and 52% had worsened diarrhoea during the treatment. 
However, the overall QoL assessed 4–6 weeks after radiotherapy was comparable with values 
measured before the treatment [20]. 
The limitation of our study was that the first QoL assessment was scheduled relatively shortly after 
surgery. Nevertheless, our primary aim was to determine the suitability of QoL evaluation in a 
homogenous group of patients with CRC and implement this method into practice. Thus, we 
created conditions for long-term follow-up and QoL evaluation as a component of complex care 
of patients with CRC.   
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CONCLUSION 
In addition to routinely monitored data during complex treatment of patients with CRC (length of 
stay, blood loss, early and late complications, overall survival, disease free interval etc.), QoL is 
an equally important outcome of medical, surgical, and nursing interventions. The QoL reflects 
the individual postoperative limitations of everyday activities and provides a feedback on how the 
treatment affects patients’ lives. Currently, non-physician health care professionals are getting 
more involved in data collection and evaluation. 
A significant correlation between the QoL score and the type of treatment was found in our study. 
Neoadjuvant CRT and surgery with stoma seemed to have a negative effect on overall QoL. 
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Table 1 – General characteristics of study cohort 
 
Gender Age Surgical procedure Colon cancer Rectal cancer 
Men Women ≥ 65 < 65 
Colon 
cancer 
Rectal 
cancer 
Without 
stoma With stoma 
Without 
stoma 
With 
stoma 
20 10 18 12 19 11 14 5 6 5 
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Table 2 - Evaluation of quality of life in patients with colon cancer (group 1) and rectal cancer (group 2) 
 
score1 Time point Group 1 (N = 19)4,5 Group 2 (N = 11)4,5 p2 
QL2 
Global health 
status 
At entry 43.4 (23.7) 42.4 (23.7) 0.912 
1 month 52.6 (24.5) 47.7 (16.7) 0.562 
Difference 9.2 (-5.4; 23.9) 5.3 (-17.7; 28.3) 
p3 0.203 0.618  
BP 
Buttock pain 
At entry 17.5 (23.2) 27.3 (32.7) 0.350 
1 month 7.0 (17.8) 45.5 (27.0) 0.001 
Difference -10.5 (-21.3; 0.3) 18.2 (-5.0; 41.4) 
p3 0.055 0.111  
DM 
Dry mouth 
At entry 31.6 (30.4) 33.3 (33.3) 0.884 
1 month 19.3 (25.6) 36.4 (18.0) 0.042 
Difference -12.3 (-29.4; 4.8) 3.0 (-20.4; 26.4) 
p3 0.149 0.779  
IMP4 
Impotence 
At entry 20.5 (32.0) 9.5 (16.3) 0.41 
1 month 25.6 (38.9) 0.0 (0.0) 0.035 
Difference 5.1 (-13.0; 23.2) -9.5 (-24.6; 5.5) 
p3 0.549 0.172  
SS 
Sore skin 
without stoma 
At entry 15.7 (23.9) 20.0 (28.1) 0.675 
1 month 11.9 (21.1) 38.9 (32.8) 0.039 
Difference -5.1 (-16.3; 6.0) 22.2 (-6.3; 50.8) 
p3 0.337 0.102  
 
1 - Data are presented as means with standard deviation and mean difference with a 95% confidence 
interval 
2 - Results from independent t-test 
3 - Results from paired t-test 
4 - Group 1: men N = 13, women N = 6; group 2: men N = 7, women N =  4 
5 - Group 1:  with stoma at entry N = 2, without stoma at entry N = 17 
      with stoma in 1 month N = 5, without stoma in 1 month N = 14 
     Group 2:  with stoma at entry N = 1, without stoma at entry N = 10 
      with stoma in 1 month N = 5, without stoma in 1 month N = 6  
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Table 3 – The quality of life stratified by age groups (≥ 65 years and < 65 years) 
 
 
score1 Time point ≥ 65 (N = 18)4,5 < 65 (N = 12)4,5 p2 
QL2  
Global health 
status  
At entry 51.4 (24.5) 30.6 (14.8) 0.007 
1 month 52.8 (26.4) 47.9 (12.9) 0.508 
Difference 1.4 (-16.0; 18.8) 17.4 (2.8; 31.9) 
p3 0.868 0.023  
SEXM4  
Sexual interest 
(men)  
At entry 33.3 (20.1) 8.3 (23.6) 0.020 
1 month 30.6 (22.3) 4.2 (11.8) 0.007 
Difference -2.8 (-13.7; 8.1) -4.2 (-14.0; 5.7) 
p3 0.586 0.351  
FA  
Fatigue  
At entry 24.7 (22.7) 50.0 (33.0) 0.019 
1 month 40.1 (23.8) 47.2 (20.7) 0.408 
Difference 15.4 (4.4; 26.5) -2.8 (-21.8; 16.3) 
p3 0.009 0.754  
CO 
Constipation  
At entry 24.1 (35.8) 58.3 (45.2) 0.028 
1 month 16.7 (30.8) 8,3 (15.1) 0.334 
Difference -7.4 (-25.9; 11.1) -50.0 (-81.9; -18.1) 
p3 0.409 0.005  
FI 
Financial 
difficulties  
At entry 18.5 (28.5) 16.7 (26.6) 0.859 
1 month 42.6 (35.8) 13.9 (22.3) 0.020 
Difference 24.1 (10.4; 37.8) -2.8 (-13.7; 8.1) 
p3 0.002 0.586  
 
1 - Data are presented as means with standard deviation and mean difference with 95% confidence 
interval 
2 - Results from independent t-test 
3 - Results from paired t-test 
4 - Group 1: men N = 12, women N = 6; group 2: men N = 8, women N =  4 
5 - Group 1:  with stoma at entry N = 1, without stoma at entry N = 17 
      with stoma in 1 month N = 4, without stoma in 1 month N = 14 
     Group 2:  with stoma at entry N = 2, without stoma at entry N = 10 
      with stoma in 1 month N = 6, without stoma in 1 month N = 6 
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Table 4 – The outcomes of quality of life evaluation in patients with CRC stratified by gender 
 
 
score1 Time point Men (N = 20)4 Women (N = 10)5 p2 
QL2  
Global health 
status  
At entry 40.8 (19.7) 47.5 (29.9) 0.469 
1 month 47.1 (22.3) 58.3 (19.6) 0.188 
Difference 6.3 (-7.4; 19.9) 10.8 (-15.5; 37.2) 
p3 0.349 0.377  
BI 
Body image 
At entry 75.6 (26.4) 61.1 (29.3) 0.184 
1 month 72.2 (23.5) 48.9 (31.9) 0.031 
Difference -3.3 (-14.0; 7.4) -12.2 (-32.9; 8.5) 
p3 0.522 0.214  
ANX 
Anxiety 
At entry 63.3 (28.4) 36.7 (29.2) 0.023 
1 month 58.3 (32.2) 46.7 (23.3) 0.318 
Difference -5.0 (-14.2; 4.2) 10.0 (-12.6; 32.6) 
p3 0.267 0.343  
CO 
Constipation 
At entry 40.0 (41.3) 33.3 (47.1) 0.694 
1 month 20.0 (29.4) 0.0 (0.0) 0.007 
Difference -20.0 (-42.3; 2.3) -33.3 (-67.1; 0.4) 
p3 0.076 0.052  
 
1 - Data are presented as means with standard deviation and mean difference with 95% confidence 
interval 
2 - Results from independent t-test 
3 - Results from paired t-test 
4 - Men:  with stoma at entry N = 1, without stoma at entry N = 19 
              with stoma in 1 month N = 7, without stoma in 1 month N = 13 
5 - Women:  with stoma at entry N = 2, without stoma at entry N = 8 
      with stoma in 1 month N = 3, without stoma in 1 month N = 7  
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Table 5 - Evaluation of quality of life in patients with and without stoma 
 
 
 
 
1 - Data are presented as means with standard deviation and mean difference with 95% confidence 
interval 
2 - Results from independent t-test 
3 - Results from paired t-test 
4 - Group 1: men N = 7, women N = 3; group 2: men N = 13, women N =  7 
5 - Group 1:  with stoma at entry N = 2, without stoma at entry N = 8 
      with stoma in 1 month N = 10, without stoma in 1 month N = 0 
     Group 2:  with stoma at entry N = 1, without stoma at entry N = 19 
      with stoma in 1 month N = 0, without stoma in 1 month N = 20 
  
score1 Time point 
With stoma4,5 
(N = 10) 
Without stoma 4,5 
(N = 20) 
p2 
QL2  
Global health 
status  
At entry 36.7 (17.7) 46.3 (25.4) 0.296 
1 month 49.2 (15.4) 51,7 (24.7) 0.773 
Difference 12.5 (-3.0; 28.0) 5,4 (-11.2; 22.0) 
p3 0.101 0.503  
PF2  
Physical 
functioning  
At entry 75.3 (21.1) 87.0 (15.8) 0.100 
1 month 48.0 (22.8) 70.7 (25.2) 0.024 
Difference -27.3 (-47.9; -6.8) -16.3 (-26.2; -6.5) 
p3 0.015 0.003  
FA  
Fatigue  
At entry 50.0 (31.5) 27.2 (26.1) 0.045 
1 month 54.4 (18.5) 37.2 (22.6) 0.047 
Difference 4.4 (-13.2; 22.1) 10.0 (-3.2; 23.2) 
p3 0.583 0.128  
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Table 6 - Evaluation of quality of life in rectal cancer patients without (group 1) and with completed 
neoadjuvant chemoradiotherapy (group 2) 
 
 
score1 Time point Group 1 (N = 2)4,5 Group 2 (N = 9)4,5 p2 
QL2  
Global health 
status  
At entry 45.8 (5.9) 41.7 (26.4) 0.835 
1 month 50.0 (23.6) 47.2 (16.7) 0.844 
Difference 4.2 (-260.5; 268.9) 5.6 (-22.7; 33.8) 
p3 0.874 0.663  
CF  
Cognitive 
functioning  
At entry 100.0 (0.0) 79.6 (18.2) 0.010 
1 month 91.7 (11.8) 81.5 (17.6) 0.464 
Difference -8.3 (-114.2; 97.6) 1.9 (-17.8; 21.5) 
p3 0.500 0.999  
BMS 
Blood and mucus 
in stool 
At entry 58.3 (58.9) 20.4 (18.2) 0.528 
1 month 0.0 (0.0) 13.0 (13.9) 0.023 
Difference -58.3 (-587.8; 471.1) -7.4 (-27.8; 13.0) 
p3 0.395 0.426  
 
1 - Data are presented as means with standard deviation and mean difference with 95% confidence 
interval 
2 - Results from independent t-test 
3 - Results from paired t-test 
4 - Group 1: men N = 1, women N = 1; Group 2: men N = 6, women N = 3 
5 - Group 1:  with stoma at entry N = 0, without stoma at entry N = 2 
      with stoma in 1 month N = 1, without stoma in 1 month N = 1 
     Group 2:  with stoma at entry N = 1, without stoma at entry N = 8 
      with stoma in 1 month N = 4, without stoma in 1 month N = 5 
 
 
 
